Posted by Michael Wonder on 21 May 2021
EMA issues advice on use of sotrovimab (VIR-7831) for treating COVID-19
21 May 2021 - EMA’s CHMP has completed its review on the use of the monoclonal antibody sotrovimab (also known as VIR-7831 and GSK4182136) to treat patients with COVID-19.
This review was undertaken to provide a harmonised scientific opinion at EU level to support national decision-making on the possible use of the antibody prior to marketing authorisation.
